Trials / Completed
CompletedNCT01375062
Obtaining Undifferentiated Cells From Testis Biopsy
Isolation, Culture and Characterization Stem Cells From Testis Biopsy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Igenomix · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to isolate and culture stem cell from adult human testicular biopsies for future transplantation in fertility preservation.
Detailed description
Testicular biopsies were obtained from azoospermic patients as part of their diagnosis and work-up after obtaining a signed informed consent. A portion of each sample was mechanically dissected in PBS with 1% Pen/Strep. For enzymatic digestion samples were incubated with 0.5g/ml Collagenase type 1A for 20min and TripLE Select for 15min at 37ºC on a shaker and then filtered with 30µm and centrifuged at 1,000rpm. The pellets were seeded and incubated in embryonic stem cell media (hESC) with glial cell line-derived neurotrophic factor (GDNF 4ng/mL) for 5-7 days at 37ºC (1st culture). To identify and isolate SSCs they were marked with CD49f antibody and FACS sorted. Positive cells were cultured in gelatine plates containing hESC media with leukaemia inhibitory factor (LIF1000U/mL) (2nd culture).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | analyse and proliferate the cells | 1. Obtention of excess tissue from testicular biopsies and maintained in 4ºC until procedures. 2. Digestion of the biopsies through controlled enzymes 3. Replication of the cells 4. Selection undifferentiated cells 5. Expansion of the purification cells population 6. Characterization of the cell population 7. Assessment of pluripotent and germinal cell potential. 8. Possible maturation of the cells. |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2011-07-01
- Completion
- 2011-07-01
- First posted
- 2011-06-17
- Last updated
- 2015-10-19
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01375062. Inclusion in this directory is not an endorsement.